BRCA1 and breast cancer: The largest risk difference was seen for women with a first breast cancer diagnosis before the age of 40, with BRCA1 heterozygotes at the 5th percentile of the ER-negative PRS313 having a 10- and 20-year risk of 22% and 35% compared with 32% and 49% at the 95th percentile, respectively.